A new @CDCMMWR reaffirms the Advisory Committee on Immunization Practices (ACIP) recommended use of the Johnson & Johnson #COVID19 Vaccine. ACIP determined that the vaccine’s known and potential benefits outweigh its known and potential risks. More: https://t.co/JNOVWW1T4b https://t.co/SpLpQXTh78